Italian Lung Cancer Observational Study

Summary

LUCENT is an observational study focused on malignant pulmonary and tracheo-bronchial disease. It involves a large proportion of reference Italian thoracic surgery centers. The relevance of the study is related to the epidemiology of lung cancer in the world - also known as "Big Killer" - and the high mortality rates both in males and females.

The aim of his prospective study is to collect a large bulk of postoperative patients' outcome data and to produce up-to-date descriptive statistics of patients undergoing surgery for lung cancer. These results will be pivotal to compare the clinical results of all the relevant specialities involved in the care of lung cancer such as medical oncologists and radiation oncologists.

Conditions

• Lung Cancer

Sponsors & Collaborators

• S. Andrea Hospital

  collaborator OTHER

• Azienda Policlinico Umberto I

  collaborator OTHER

• Azienda Ospedaliero, Universitaria Pisana

  collaborator OTHER

• Università degli Studi dell'Aquila

  collaborator OTHER

• University of Milan

  collaborator OTHER

• Azienda Ospedaliera di Perugia

  collaborator OTHER

• Monaldi Hospital

  collaborator OTHER

• Azienda Ospedaliera di Bolzano

  collaborator OTHER

• AUSL Romagna Rimini

  collaborator OTHER

• European Institute of Oncology

  collaborator OTHER

• Università degli Studi di Ferrara

  collaborator OTHER

• Azienda Socio Sanitaria Territoriale di Mantova

  collaborator OTHER

• The Mediterranean Institute for Transplantation and Advanced Specialized Therapies

  lead OTHER

Principal Investigators

• Roberto Crisci, MD · University of Aquila

• Luca Bertolaccini, MD · European Institute of Oncology

• Alessandro Bertani, MD · IRCCS ISMETT -UPMC ITALY

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2023-04-01

Primary Completion

2028-03-31

Completion

2028-03-31

Countries

• Italy

Study Locations